Literature DB >> 9219697

In vitro propagation of the prion-like state of yeast Sup35 protein.

S V Paushkin1, V V Kushnirov, V N Smirnov, M D Ter-Avanesyan.   

Abstract

The yeast cytoplasmically inherited genetic determinant [PSI+] is presumed to be a manifestation of the prion-like properties of the Sup35 protein (Sup35p). Here, cell-free conversion of Sup35p from [psi-] cells (Sup35ppsi-) to the prion-like [PSI+]-specific form (Sup35pPSI+) was observed. The conversion reaction could be repeated for several consecutive cycles, thus modeling in vitro continuous [PSI+] propagation. Size fractionation of lysates of [PSI+] cells demonstrated that the converting activity was associated solely with Sup35pPSI+ aggregates, which agrees with the nucleation model for [PSI+] propagation. Sup35pPSI+ was purified and showed high conversion activity, thus confirming the prion hypothesis for Sup35p.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219697     DOI: 10.1126/science.277.5324.381

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  87 in total

1.  Mutational analysis of the [Het-s] prion analog of Podospora anserina. A short N-terminal peptide allows prion propagation.

Authors:  V Coustou; C Deleu; S J Saupe; J Bégueret
Journal:  Genetics       Date:  1999-12       Impact factor: 4.562

2.  Evidence for a protein mutator in yeast: role of the Hsp70-related chaperone ssb in formation, stability, and toxicity of the [PSI] prion.

Authors:  Y O Chernoff; G P Newnam; J Kumar; K Allen; A D Zink
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

3.  Dependence and independence of [PSI(+)] and [PIN(+)]: a two-prion system in yeast?

Authors:  I L Derkatch; M E Bradley; S V Masse; S P Zadorsky; G V Polozkov; S G Inge-Vechtomov; S W Liebman
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

4.  Strains of [PSI(+)] are distinguished by their efficiencies of prion-mediated conformational conversion.

Authors:  S M Uptain; G J Sawicki; B Caughey; S Lindquist
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

5.  The [URE3] phenotype: evidence for a soluble prion in yeast.

Authors:  Eric Fernandez-Bellot; Elisabeth Guillemet; Frederique Ness; Agnes Baudin-Baillieu; Leslie Ripaud; Mick Tuite; Christophe Cullin
Journal:  EMBO Rep       Date:  2001-12-19       Impact factor: 8.807

6.  Amyloid aggregates of the HET-s prion protein are infectious.

Authors:  Marie-Lise Maddelein; Suzana Dos Reis; Stéphane Duvezin-Caubet; Bénédicte Coulary-Salin; Sven J Saupe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

7.  Two prion-inducing regions of Ure2p are nonoverlapping.

Authors:  M L Maddelein; R B Wickner
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

8.  Mtt1 is a Upf1-like helicase that interacts with the translation termination factors and whose overexpression can modulate termination efficiency.

Authors:  K Czaplinski; N Majlesi; T Banerjee; S W Peltz
Journal:  RNA       Date:  2000-05       Impact factor: 4.942

9.  Prion properties of the Sup35 protein of yeast Pichia methanolica.

Authors:  V V Kushnirov; N V Kochneva-Pervukhova; M B Chechenova; N S Frolova; M D Ter-Avanesyan
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

10.  Progress toward an ultimate proof of the prion hypothesis.

Authors:  Susan W Liebman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.